COVID–19 Data Accuracy Act

Bill: 116-hr-8811
Sponsor: full_name: Rep. Finkenauer, Abby [D-IA-1]
Introduced: 2020-11-24
Policy area: Health
Subjects: Cardiovascular and respiratory health

Computers and information technology

Congressional oversight

Department of Health and Human Services

Emergency medical services and trauma care

Government information and archives

Government studies and investigations

Health information and medical records

Health technology, devices, supplies

Hospital care

Infectious and parasitic diseases

Military civil functions

National Guard and reserves

State and local government operations
Latest action: action_date: 2020-11-24
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2020-11-24
action_desc: Introduced in House
text: <p><b>COVID-19 Data Accuracy Act</b></p> <p>This bill directs the Government Accountability Office (GAO) to initiate an inquiry within seven days and report on the impact of certain changes to hospital reporting requirements for COVID-19 (i.e., coronavirus disease 2019) on data quality, transparency, and access. The White House's Coronavirus Task Force revised the process for hospitals to report COVID-19 data on July 13, 2020; previously, hospitals reported data to the Centers for Disease Control and Prevention (CDC) instead of to the Department of Health and Human Services (HHS).</p> <p>To facilitate the inquiry, HHS must provide the GAO with direct access to relevant information systems. The GAO must present its findings within 45 days, and HHS must then respond to the findings and rectify any issues identified within 7 days.</p> <p>HHS must also, in coordination with the CDC, develop a process within 30 days to correct inaccuracies in the COVID-19 data.</p> <p>In addition, the GAO must issue reports that address, for example, the impact of the changes to reporting requirements on federal and nonfederal entities, such as hospitals, states, and other jurisdictions, and information about how the decision to change those requirements was made.</p>

tv_txt: I 116th CONGRESS 2d Session H. R. 8811 IN THE HOUSE OF REPRESENTATIVES November 24, 2020 Ms. Finkenauer (for herself, Mr. Loebsack , and Mrs. Axne ) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To initiate an inquiry and report on COVID–19 data quality, sharing, transparency, access, and analysis and develop a process to correct inaccurate information reported with respect to the COVID–19 public health emergency, and for other purposes.

1. Short title This Act may be cited as the COVID–19 Data Accuracy Act . 2. Protecting data quality, sharing, transparency, access, and analysis (a) Inquiry and submission (1) In general Not later than 7 days after the date of the enactment of this Act, the Comptroller General shall initiate an inquiry into any changes or interruptions in data quality, sharing, transparency, access, and analysis or access to relevant analytics resulting from the changes to COVID–19 hospital data reporting requirements initiated by the White House Coronavirus Task Force and the Department of Health and Human Services on July 13, 2020. (2) Submission of findings Not later than 45 days after initiation of an inquiry under paragraph (1), the Comptroller General shall submit findings with respect to such inquiry to the Committee on Energy and Commerce of the House of Representatives, the Committee on Health, Education, Labor, and Pensions of the Senate, and the Department of Health and Human Services, in oral briefings, which shall address— (A) any changes or interruptions described in paragraph (1), including whether such changes increased, decreased, expedited, or delayed the data quality, sharing, transparency, access, and analysis or access to relevant analytics, with respect to— (i) the public; (ii) State, local, Tribal, and territorial health departments; (iii) hospitals; and (iv) Federal agency officials, including officials in the Department of Health and Human Services and Centers for Disease Control and Prevention; and (B) any impact to, or interruptions in, delivery of supplies, including personal protective equipment, ventilators, and COVID–19 therapeutics, to States or other entities resulting from any changes or interruptions described in paragraph (1). (b) Access to reporting system The Secretary shall, not later than 7 days after the date of enactment of this Act, provide the Comptroller General with access to the information technology systems maintained by the Department of Health and Human Services to enable the Comptroller General to independently access, view, download, and retrieve data from such systems for the purpose of carrying out this section. (c) Addressing issues Not later than 7 days after the Comptroller General submits the findings to Congress pursuant to subsection (a)(2), the Secretary shall— (1) correct any decreases or delays identified by the Comptroller General in the findings; (2) address issues with respect to data quality, sharing, transparency, access, and analysis and access to relevant analytics; and (3) ensure that such data quality, sharing, transparency, access, and analysis and access to relevant analytics are equal to or better than they were as of July 12, 2020. (d) Report Not later than 18 months after the date of the enactment of this Act, the Comptroller General shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a report on the impact of changes or interruptions to COVID–19 hospital data reporting requirements described in subsection (a). In preparing such report, the Comptroller General shall collect information from relevant stakeholders, as appropriate. Such report shall— (1) detail any such changes or interruptions to data quality, sharing, transparency, access, and analysis, or access to relevant analytics, for the entities described in subsection (a)(2)(A), including whether such changes or interruptions increased, decreased, expedited, or delayed such data or access to relevant analytics; (2) describe challenges faced by hospitals, States, localities, Indian Tribes (as defined in section 4 of the Indian Self-Determination and Education Assistance Act ( 25 U.S.C. 5304 )), Urban Indian organizations (as defined in section 4 of the Indian Health Care Improvement Act ( 25 U.S.C. 1603 )), territories, Federal agencies, and the public resulting from such changes or interruptions; (3) describe the extent to which such changes or interruptions may allow for manipulation of such data in a manner that results in the entities described in paragraph (2) receiving information that is different from information provided to the Department of Health and Human Services; (4) assess the extent to which such changes or interruptions increased or decreased the number of hospitals reporting data and the completeness and quality of data reported by hospitals; (5) determine whether any States deployed the National Guard to assist in hospital data reporting (as suggested in communications from the White House Coronavirus Task Force and the Department of Health and Human Services on July 13, 2020) and whether any such deployment had a measurable effect on the speed, content, or quality of such reporting; (6) describe the decision-making process within the Department of Health and Human Services that led to the changes initiated on July 13, 2020, including— (A) the role of the Centers for Disease Control and Prevention in such process; (B) any analysis conducted by the Department of Health and Human Services or the Centers for Disease Control and Prevention that assessed the quality and completeness of different data streams (including the National Healthcare Safety Network, TeleTracking, and data reported by States to the Protect System of the Department of Health and Human Services), prior to July 13, 2020; (C) any external input into the decision-making process, including from other Federal agencies, States, localities, Indian Tribes (as defined in section 4 of the Indian Self-Determination and Education Assistance Act ( 25 U.S.C. 5304 )), Urban Indian organizations (as defined in section 4 of the Indian Health Care Improvement Act ( 25 U.S.C. 1603 )), territories, or hospitals; (D) the public health justification for the changes; and (E) any other justification for such changes; and (7) assess the process used to address— (A) decreases or delays identified under subsection (c)(1); and (B) issues described in subsection (c)(2). (e) Interim report Not later than 6 months after the date of the enactment of this Act, the Comptroller General shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate an interim report on the initial findings with respect to information required to be in the report under subsection (d). 3. Correcting inaccuracies (a) In general Not later than 30 days after the date of the enactment of this Act, the Secretary shall, in coordination with the Director of the Centers for Disease Control and Prevention and reporting entities, develop a process to correct inaccurate information collected, reported, or distributed with respect to the COVID–19 public health emergency declared pursuant to section 319 of the Public Health Service Act ( 42 U.S.C. 247d ). (b) Requirements The process under subsection (a) shall— (1) identify and correct inaccurate information in a timely manner; (2) consider data made available by— (A) the Department of Health and Human Services and the Centers for Disease Control and Prevention; and (B) reporting entities (including data provided to the Secretary in accordance with the State plans referred to in subsection (e)); (3) permit the public to report on inaccurate information described in subsection (a); and (4) include technical assistance, as necessary, for reporting entities. (c) Public notification The Secretary shall, in a manner that protects personally identifiable information from disclosure and complies with applicable Federal law on privacy— (1) in a timely manner, notify the public of— (A) inaccurate information identified pursuant to the process developed under subsection (a); and (B) the steps used to correct the inaccurate information; and (2) after notifying the public under paragraph (1), in a reasonable period of time, make a public certification that such inaccurate information has been corrected. (d) Guidance Not later than 30 days after the date of the enactment of this Act, the Secretary shall issue guidance to reporting entities with respect to identifying and correcting inaccurate information described in subsection (a) in the data collected, reported, or distributed by such agencies. Such guidance shall include a method— (1) to notify the Secretary when such inaccurate information is identified; and (2) to collaborate with the Secretary to correct and notify the public of such inaccurate information in accordance with subsection (c). (e) State plans Not later than 60 days after the date of the enactment of this Act, the Secretary shall require each State that submitted to the Secretary a COVID–19 testing plan under the heading “Public Health and Social Services Emergency Fund” in title I of division B of the Paycheck Protection Program and Health Care Enhancement Act ( Public Law 116–139 ) to update the plan to include a process for correcting inaccurate information described in subsection (a) based on the guidance issued under subsection (d). (f) Reports (1) Preliminary reports Not later than 90 days after the date of the enactment this Act, and every 30 days thereafter, the Secretary shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor, and Pensions of the Senate a preliminary report on— (A) the inaccurate information that is corrected the most through the process developed under subsection (a); and (B) best practices for identifying, correcting, and notifying the public of such inaccurate information. (2) Final report Not later than 3 months after the end of the public health emergency described in subsection (a), the Secretary shall submit to the committees referred to in paragraph (1) a final report on— (A) the inaccurate information described in paragraph (1)(A); and (B) the effectiveness of the process developed under subsection (a) to address such inaccurate information. 4. Definitions In this Act: (1) Comptroller General The term Comptroller General means the Comptroller General of the United States. (2) Reporting entities The term reporting entities means State, territorial, and local health departments, hospitals, and any other entity that either directly or indirectly reports information to the Secretary with respect to the COVID–19 public health emergency declared pursuant to section 319 of the Public Health Service Act ( 42 U.S.C. 247d ). (3) Secretary The term Secretary means the Secretary of Health and Human Services.